American Oncology Network Inc-A 2024年度报告

FORM 10-K xANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended December 31, 2024oroTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 Commission file number 001-04321 American Oncology Network, Inc.(Exact name of registrant as specified in its charter)Delaware85-3984427 (State or other jurisdiction of incorporation ororganization) (I.R.S. Employer Identification No.) 14543 Global Parkway, Suite 110, Fort Myers,Florida (833) 886-1725Registrant's telephone number, including area code Securities registered pursuant to Section 12(b) of the Act: Securities registered pursuant to section 12(g) of the Act: NoneIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of theSecurities Act.Yes o No x Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section15(d) of the Act. Yes o No x Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periodthat the registrant was required to file such reports); and (2) has been subject to such filing requirementsfor the past 90 days.Yes x No o Indicate by check mark whether the registrant has submitted electronically and posted on its corporateweb site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 ofRegulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period thatthe registrant was required to submit and post such files). Yes x No oIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non- accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,”“accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use theextended transition period for complying with any new or revised financial accounting standards providedpursuant to Section 13(a) of the Exchange Act. o Indicate by check mark whether the registrant has filed a report on and attestation to its management’sassessment of the effectiveness of its internal control over financial reporting under Section 404(b) of theSarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issuedits audit report. If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether thefinancial statements of the registrant included in the filing reflect the correction of an error to previouslyissued financial statements. o Indicate by check mark whether any of those error corrections are restatements that required analysis ofincentive-based compensation received by any of the registrant’s executive officers during the relevantrecovery period pursuant to §240.10D-1(b). o Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).Yes o No x The aggregate market value of the voting and non-voting common stock held by non-affiliates of theregistrant, as of June 30, 2024, the last day of the registrant’s most recently completed second fiscalquarter, was approximately $7,988,383. As of March 24, 2025, the registrant had outstanding 32,087,737 shares of Class A common stock,inclusive of the Sponsor Earnout shares, and 14,867,850 shares of Class B common stock. Table of Contents TABLE OF CONTENTS Item 2. Properties41Item 3. Legal Proceedings42Item 4. Mine Safety Disclosures42Part II43Item 5. Market for Registrant's Common Equity, Related Stockholder Matters andIssuer Purchases of Equity Securities43Item 6. [Reserved]43Item 7. Management's Discussion and Analysis of Financial Condition andResults of Operations44Item 7A. Quantitative and Qualitative Disclosures About Market Risk56Item 8. Financial Statements and Supplementary Data56Report of Independent Registered Public Accounting Firm58Consolidated Balance Sheets60Consolidated Statements of Operations and Comprehensive Income (Loss)62Consolidated Statements of Mezzanine and Stockholders’ Equity64Consolidated Statements of Cash Flows66Notes to Consolidated Financial Statements68Item 9. Changes in and Disagreements With Accountants on Accounting andFinancial Disclosures114Item 9A. Controls and Procedures114Item 9B. Other Information118Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections118Part III119Item 10. Directors, Executive Officers and Corporate Governance119Item 11. Executive Compensation124Item 12. Security Ownership of Certain Beneficial Owner and Management andRelated Stockholder Matters127Item 13. Certain Relationships and Related Transactions, and DirectorIndependence129Item 14. Principal Accounting Fees and Services